Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03PIF
|
||||
Former ID |
DNC008129
|
||||
Drug Name |
Salvinorin B tetrahydropyran-2-yl ether
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529133] | ||
Structure |
Download2D MOL |
||||
Formula |
C26H34O8
|
||||
Canonical SMILES |
CC12CCC3C(=O)OC(CC3(C1C(=O)C(CC2C(=O)OC)OC4CCCCO4)C)C5=<br />COC=C5
|
||||
InChI |
1S/C26H34O8/c1-25-9-7-16-24(29)34-19(15-8-11-31-14-15)13-26(16,2)22(25)21(27)18(12-17(25)23(28)30-3)33-20-6-4-5-10-32-20/h8,11,14,16-20,22H,4-7,9-10,12-13H2,1-3H3/t16-,17-,18-,19-,20?,22-,25-,26-/m0/s1
|
||||
InChIKey |
QFGJOBZLFYQWNI-UBPYUYODSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Kappa-type opioid receptor | Target Info | Inhibitor | [529133] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.